1.天津中医药大学循证医学中心(天津 301617)
强晓钰,女,硕士研究生,主要从事中医内科相关研究工作
庞博,助理研究员;E-mail:pangbo2021@163.com
张俊华,研究员,博士研究生导师;E-mail:zjhtcm@ foxmail.com
扫 描 看 全 文
强晓钰,季昭臣,生晓迪等.核心指标集方法学研究进展[J].上海中医药杂志,2022,56(08):113-117.
QIANG Xiaoyu,JI Zhaochen,SHENG Xiaodi,et al.Advances in core outcome set methodology[J].Shanghai Journal of Traditional Chinese Medicine,2022,56(08):113-117.
强晓钰,季昭臣,生晓迪等.核心指标集方法学研究进展[J].上海中医药杂志,2022,56(08):113-117. DOI: 10.16305/j.1007-1334.2022.2202041.
QIANG Xiaoyu,JI Zhaochen,SHENG Xiaodi,et al.Advances in core outcome set methodology[J].Shanghai Journal of Traditional Chinese Medicine,2022,56(08):113-117. DOI: 10.16305/j.1007-1334.2022.2202041.
为应对临床研究评价指标存在的不规范、不一致、不重要等问题,方法学专家提出了核心指标集(COS)的概念。有效性试验核心结局指标(COMET)工作组的成立,促进了COS的国际化推广和应用。从COS的概念及作用、COS研究平台、COS研制方法、中医药临床研究核心指标集(COS-TCM)等四个方面进行阐述,为核心指标集研究提供参考。
To deal with the nonstandard, inconsistent and unimportant clinical research evaluation indicators, methodologists put forward the concept of core outcome set (COS). The establishment of core outcome measures in effectiveness trials (COMET) working group has facilitated the international promotion and application of COS. This paper expounds the concept and function of COS, COS research platforms, COS development methods, and the core outcome set of traditional Chinese medicine (COS-TCM) for clinical trials, thereby providing references for the research of core outcome set.
核心指标集评价指标方法学中医药学循证医学临床试验
core outcome setevaluation indicatormethodologytraditional Chinese medicineevidence-based medicineclinical trial
张俊华,孙鑫. 循证中医药学[M]. 上海:上海科学技术出版社,2018: 1.
邢冬梅,张俊华,张伯礼. 中医临床研究核心结局指标集形成路径[J]. 中华中医药杂志,2014, 29(5): 1352-1355.
COMET. History[EB/OL].[2021-12-27]. https://www.comet-initiative.org/About/Historyhttps://www.comet-initiative.org/About/History.
张俊华,王海南. 临床评价核心指标集研究方法与实践[M]. 上海:上海科学技术出版社,2021: 3.
World Health Organization. WHO handbook for reporting results of cancer treatment[EB/OL]. [2021-12-27]. https://apps.who.int/iris/handle/10665/37200https://apps.who.int/iris/handle/10665/37200.
TUGWELL P, BOERS M. OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: introduction[J]. J Rheumatol, 1993, 20(3): 528-530.
MOKKINK L B, TERWEE C B, KNOL D L, et al. Protocol of the COSMIN study: COnsensus-based Standards for the selection of health Measurement INstruments[J]. BMC Med Res Methodol, 2006(6): 2.
DUFFY J, ROLPH R, GALE C, et al. Core outcome sets in women’s and newborn health: a systematic review[J]. BJOG, 2017, 124(10): 1481-1489.
KHAN K, Chief Editors of Journals participating in The CROWN Initiative. The CROWN Initiative: journal editors invite researchers to develop core outcomes in women’s health[J]. Contracept Reprod Med, 2016(1): 16.
天津中医药大学循证医学中心. 中国临床试验核心指标集研究中心成立并召开工作会议[EB/OL].(2019-07-23)[2021-12-27]. https://ebm.tjutcm.edu.cn/info/1074/1747.htmhttps://ebm.tjutcm.edu.cn/info/1074/1747.htm.
天津中医药大学循证医学中心. 首届“临床试验核心指标集(COS)研制方法培训班”成功举办[EB/OL].(2019-07-23)[2021-12-27]. https://ebm.tjutcm.edu.cn/info/1074/1746.htmhttps://ebm.tjutcm.edu.cn/info/1074/1746.htm.
霍文巍. 中国临床试验核心指标集研究中心在成都中医药大学成立分中心了[EB/OL].(2020-10-23)[2021-12-27]. https://www.cdutcm.edu.cn/mtsp/mtjj/content_57266https://www.cdutcm.edu.cn/mtsp/mtjj/content_57266.
循证中医药. 中医药核心指标集研究中心河南中医药大学第一附属医院分中心成立[EB/OL]. (2021-10-16)[2021-10-22]. https://baijiahao.baidu.com/s?id=1713781710473133563https://baijiahao.baidu.com/s?id=1713781710473133563.
KIRHAM J J, GORST S, ALTMAN D G, et al. Core Outcome Set-STAndards for Reporting: The COS-STAR Statement[J]. PLoS Med, 2016, 13(10): e1002148.
WILLIAMSON P R, ALTMAN D G, BAGLEY H, et al. The COMET Handbook: version 1.0[J]. Trials, 2017, 18(Suppl 3): 280.
KIRKHAM J J, DAVIS K, ALTMAN D G, et al. Core Outcome Set-STAndards for Development: The COS-STAD recommendations[J]. PLoS Med, 2017, 14(11): e1002447.
KIRKHAM J J, GORST S, ALTMAN D G, et al. Core Outcome Set-STAndardised Protocol Items: the COS-STAP Statement[J]. Trials, 2019, 20(1):116.
PRINSEN C A C, VOHRA S, ROSE M R, et al. Guideline for selecting outcome measurement instruments for outcomes included in a Core Outcome Set[EB/OL]. [2021-12-27]. http://europepmc.org/articles/PMC5020549/bin/13063_2016_1555_MOESM2_ESM.pdfhttp://europepmc.org/articles/PMC5020549/bin/13063_2016_1555_MOESM2_ESM.pdf.
PRINSEN C A C, VOHRA S, ROSE M R, et al. How to select outcome measurement instruments for outcomes included in a “Core Outcome Set”-a practical guideline[J]. Trials, 2016, 17(1): 449.
ZHANG M Y, ZHANG J H, CHUA H Z, et al. Core outcome set for stable angina pectoris in traditional Chinese medicine (COS-SAP-TCM)[J]. Acupunc Herbal Med, 2021, 1(9): 39-48.
张明妍,杨丰文,李越,等. 核心指标集报告规范:COS-STAR声明[J]. 中国循证医学杂志,2017, 17(4): 470-474.
张明妍,杨丰文,李越,等. 核心指标集报告规范(COS-STAR)介绍[J]. 中国循证医学杂志, 2017, 17(7): 857-861.
张明妍,张俊华,杜亮,等. 核心指标集研制规范(COS-STAD)介绍及其在中医药领域应用的思考[J]. 中国循证医学杂志,2018, 18(4): 392-396.
张明妍,张俊华,杜亮,等. 译文:核心指标集研制标准:COS-STAD推荐[J]. 中国循证医学杂志,2018, 18(7): 753-757.
张明妍,张俊华,张伯礼,等. 中医药临床试验核心指标集研制技术规范[J]. 中华中医药杂志,2021, 36(2): 924-928.
张俊华,李幼平,张伯礼. 循证中医药学:理论与实践[J]. 中国中药杂志,2018, 43(1): 1-7.
张明妍,杨丰文,李越,等.《中国中西医结合杂志》刊载中医药随机对照试验报告质量的研究[J]. 中国循证医学杂志,2017, 17(3): 357-363.
张俊华,孙鑫,李幼平,等. 循证中医药学的现在和未来[J]. 中国循证医学杂志,2019, 19(5): 515-520.
JIN X, PANG B, ZHANG J, et al. Core outcome set for clinical trials on coronavirus disease 2019 (COS-COVID)[J]. Engineering, 2020, 6(10): 1147-1152.
0
浏览量
532
下载量
0
CSCD
2
CNKI被引量
关联资源
相关文章
相关作者
相关机构